Adverse reactions: Any adverse reactions to the Depo-Provera injection must be documented, including the nature and severity of the reaction and any treatment provided
Research suggests it has a relatively mild safety profile, but long-term safety studies are still limited
This product is supplied exclusively for laboratory research purposes
Symptoms may include fatigue, weakness, memory problems, difficulty concentrating, mood changes, numbness or tingling in the hands and feet, and difficulty maintaining balance
User reports from peptide forums: "Maybe slightly less bad than usual." Not a dramatic difference
The authors own conclusion was that short-term DSIP was not likely to be a major therapeutic benefit